Examining the significance of fingerprint-based classifiers
暂无分享,去创建一个
[1] E. Petricoin,et al. High-resolution serum proteomic features for ovarian cancer detection. , 2004, Endocrine-related cancer.
[2] M. Eberhardson,et al. The use of proteomics in identifying differentially expressed serum proteins in humans with type 2 diabetes , 2006, Proteome Science.
[3] B. Hitt,et al. Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma. , 2005, Endocrine-related cancer.
[4] Philip J Day,et al. Artificial neural networks and decision tree model analysis of liver cancer proteomes. , 2007, Biochemical and biophysical research communications.
[5] D. Ward,et al. Identification of serum biomarkers for colon cancer by proteomic analysis , 2006, British Journal of Cancer.
[6] U. Langsenlehner,et al. A multigenic approach to predict breast cancer risk , 2007, Breast Cancer Research and Treatment.
[7] N. Anderson,et al. The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.
[8] Emanuel F Petricoin,et al. Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml. , 2004, The Journal of urology.
[9] E. Petricoin,et al. A serum proteomic approach to gauging the state of remission in Wegener's granulomatosis. , 2005, Arthritis and rheumatism.
[10] Daniel Hartmann,et al. Identification of Potential Markers for the Detection of Pancreatic Cancer Through Comparative Serum Protein Expression Profiling , 2007, Pancreas.
[11] D. Ransohoff. Lessons from controversy: ovarian cancer screening and serum proteomics. , 2005, Journal of the National Cancer Institute.
[12] C. Infante-Rivard,et al. Unexpected Relationship between Plasma Homocysteine and Intrauterine Growth Restriction , 2004 .
[13] Klaus-Robert Müller,et al. Optimal dyadic decision trees , 2007, Machine Learning.
[14] Virginia Espina,et al. Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis. , 2006, Experimental hematology.
[15] J. M. Roman,et al. Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors. , 2006, Gastroenterology.
[16] Weijian Guo,et al. Prediction of Pancreatic Cancer by Serum Biomarkers Using Surface-Enhanced Laser Desorption/Ionization-Based Decision Tree Classification , 2005, Oncology.
[17] Ming Xu,et al. Using tree analysis pattern and SELDI-TOF-MS to discriminate transitional cell carcinoma of the bladder cancer from noncancer patients. , 2005, European urology.
[18] E. Petricoin,et al. Toxicoproteomics: Serum Proteomic Pattern Diagnostics for Early Detection of Drug Induced Cardiac Toxicities and Cardioprotection , 2004, Toxicologic pathology.
[19] D. Ransohoff. Bias as a threat to the validity of cancer molecular-marker research , 2005, Nature reviews. Cancer.
[20] Wei Zhang,et al. Application of serum SELDI proteomic patterns in diagnosis of lung cancer , 2005, BMC Cancer.
[21] Feng-ping Huang,et al. Discovery of serum biomarkers in astrocytoma by SELDI–TOF MS and proteinchip technology , 2007, Journal of Neuro-Oncology.
[22] Emanuel F. Petricoin,et al. Serum Proteomic Analysis Identifies a Highly Sensitive and Specific Discriminatory Pattern in Stage 1 Breast Cancer , 2007, Annals of Surgical Oncology.
[23] Brian T. Luke,et al. Genetic algorithms and beyond , 2003 .
[24] William E Grizzle,et al. Clarification in the point/counterpoint discussion related to surface-enhanced laser desorption/ionization time-of-flight mass spectrometric identification of patients with adenocarcinomas of the prostate. , 2004, Clinical chemistry.
[25] Steven A Carr,et al. Place of pattern in proteomic biomarker discovery. , 2005, Journal of proteome research.
[26] Nico Nagelkerke,et al. Developing a Discrimination Rule between Breast Cancer Patients and Controls Using Proteomics Mass Spectrometric Data: A Three-Step Approach , 2008, Statistical applications in genetics and molecular biology.
[27] Richard M. Simon,et al. A Paradigm for Class Prediction Using Gene Expression Profiles , 2003, J. Comput. Biol..
[28] Bao-xue Yang,et al. Application of surface-enhanced laser desorption/ionization time-of-flight-based serum proteomic array technique for the early diagnosis of prostate cancer. , 2006, Asian journal of andrology.
[29] E. Petricoin,et al. Putting the "bio" back into biomarkers: orienting proteomic discovery toward biology and away from the measurement platform. , 2008, Clinical chemistry.
[30] E. Petricoin,et al. The blood peptidome: a higher dimension of information content for cancer biomarker discovery , 2006, Nature Reviews Cancer.
[31] Wen-Qi Jiang,et al. Serum diagnosis of diffuse large B-cell lymphomas and further identification of response to therapy using SELDI-TOF-MS and tree analysis patterning , 2007, BMC Cancer.
[32] D. Kwong,et al. Surface‐enhanced laser desorption/ionization time‐of‐flight mass spectrometry serum protein profiling to identify nasopharyngeal carcinoma , 2006, Cancer.
[33] P. Schellhammer,et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. , 2002, Cancer research.
[34] Andrew Kusiak,et al. Cancer gene search with data-mining and genetic algorithms , 2007, Comput. Biol. Medicine.